HomeMarkets Markets Moderna’s mRNA RSV vaccine delivers impressive Phase 3 trial results By news January 19, 2023 0 20 FacebookTwitterPinterestWhatsApp Biotechnology company Moderna has announced promising results from its massive Phase 3 trial testing an mRNA vaccine for respiratory syncytial virus …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected159,283FansLike406,828FollowersFollow2,160SubscribersSubscribe Latest Articles Markets Massive Hawkish Reversal In Rate-Hike Odds Sparks Greenback Gains, Bond Bloodbath Markets The Annual Interest Rate Payment on Government Debt Is $850 Billion And Rising Fast Markets Goldman Hikes 3 Month S&P Target By 400 Points To 4,000 As Chief Economist Slashes Recession Odds Markets Cars Increasingly Ready For Autonomous Driving Markets Dell Cuts 6,650 Jobs Due To “Challenging Global Economic Environment” Load more